{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-016977","form_type":"8-K","ticker":"MGTX","cik":"0001735438","company_name":"MeiraGTx Holdings plc","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.259233+00:00","generated_at":"2026-06-09T06:07:06.913236+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"MeiraGTx announces $30M Sanofi investment at $7.50/share; exploring additional strategic transactions","bullets":["Sanofi subsidiary purchased 4M ordinary shares at $7.50 each for gross proceeds of $30M; shares subject to 18-month lock-up and standstill for 24 months.","Sanofi receives right of first negotiation for Riboswitch gene regulation tech in I&I, CNS, metabolic targets and MeiraGTx's Phase 2 Xerostomia program.","MeiraGTx has been approached by multiple parties with strategic interest in different assets; engaged Evercore and Wachtell Lipton to evaluate potential transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-016977","json":"https://secwatch.observer/filing/0001558370-23-016977.json","markdown":"https://secwatch.observer/filing/0001558370-23-016977.md","text":"https://secwatch.observer/filing/0001558370-23-016977.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1735438/000155837023016977/0001558370-23-016977-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1735438/000155837023016977/mgtx-20231030x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T06:07:06.913236+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"450325e4e8bb113f1b15fdaffd830ad0487821e8","claim":"MeiraGTx Holdings plc entered into Investment Agreement with Sanofi Foreign Participations B.V. valued at 4,000,000 ordinary shares at $7.50 per share for gross proceeds of $30.0 million (effective 2023-10-30).","evidence_excerpt":"On October 30, 2023 (the “Closing Date”), MeiraGTx Holdings plc (the “Company”) entered into an Investment Agreement (the “Investment Agreement”) with Sanofi Foreign Participations B.V. (the “Investor”), a wholly-owned subsidiary of Sanofi, and solely for the limited purposes set forth therein, Sanofi (the “Parent”), pursuant to which, among other things and subject to the terms and conditions specified therein, the Company issued an aggregate of 4,000,000 ordinary shares, nominal value $0.00003881 (the “Shares”), at a purchase price of $7.50 per share (the “Private Placement”) for gross proceeds of $30.0 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1735438/000155837023016977/0001558370-23-016977-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Sanofi Foreign Participations B.V."},{"label":"Value","value":"4,000,000 ordinary shares at $7.50 per share for gross proceeds of $30.0 million"},{"label":"Effective","value":"2023-10-30"}],"fact_type":"material_agreement"},{"claim_id":"a7edbe398a32a4080ea8703a75a822924bef2afd","claim":"MeiraGTx Holdings plc entered into Registration Rights Agreement with Sanofi Foreign Participations B.V. valued at Company obligated to file registration statement to register Shares for resale on or prior to April (effective 2023-10-30).","evidence_excerpt":"In connection with the Private Placement, the Company also entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Investor.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1735438/000155837023016977/0001558370-23-016977-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Sanofi Foreign Participations B.V."},{"label":"Value","value":"Company obligated to file registration statement to register Shares for resale on or prior to April"},{"label":"Effective","value":"2023-10-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}